STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Avadel Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Avadel Pharmaceuticals (Nasdaq: AVDL) announced its management team will participate in a fireside chat at the Jefferies Global Healthcare Conference on June 5, 2025, at 10:30 a.m. ET. The presentation will be available via webcast on the company's investor relations website at investors.avadel.com, with the recording remaining accessible for 90 days after the event.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

+1.88% News Effect

On the day this news was published, AVDL gained 1.88%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

DUBLIN, Ireland, May 29, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 5 at 10:30 a.m. ET.

A live webcast of the fireside chat, as well as an archived recording, will be available on Avadel’s Investor Relations website, investors.avadel.com, for 90 days following the conference.

About Avadel Pharmaceuticals plc

Avadel Pharmaceuticals plc (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. Our approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options. Avadel’s commercial product, LUMRYZ™, was approved by the U.S. Food & Drug Administration (FDA) as the first and only once-at-bedtime oxybate for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years and older with narcolepsy. For more information, please visit www.avadel.com.

Investor Contact:
Austin Murtagh
Precision AQ
Austin.Murtagh@precisionAQ.com 
(212) 698-8696

Media Contact:
Lesley Stanley
Real Chemistry
lestanley@realchemistry.com 
(609) 273-3162


FAQ

When is Avadel Pharmaceuticals (AVDL) presenting at the Jefferies Global Healthcare Conference 2025?

Avadel Pharmaceuticals will present at the Jefferies Global Healthcare Conference on Thursday, June 5, 2025, at 10:30 a.m. ET.

Where can I watch Avadel Pharmaceuticals' (AVDL) Jefferies conference presentation?

The presentation can be watched via webcast on Avadel's Investor Relations website at investors.avadel.com. The recording will be available for 90 days following the conference.

What type of presentation will Avadel Pharmaceuticals (AVDL) give at the Jefferies conference?

Avadel Pharmaceuticals' management will participate in a fireside chat format presentation at the conference.

How long will Avadel Pharmaceuticals' (AVDL) Jefferies conference presentation be available online?

The presentation recording will be available on Avadel's Investor Relations website for 90 days following the conference.
Avadel Pharmaceu

NASDAQ:AVDL

AVDL Rankings

AVDL Latest News

AVDL Latest SEC Filings

AVDL Stock Data

2.09B
97.12M
4.89%
86.45%
10.8%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
Ireland
DUBLIN 2